Navigation Links
Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes'

Register for an Educational Webinar "How Organizations Can Make the Transition to SPL R4 Compliance," Hosted by Pilgrim Software and featuring Virtify, Inc.

CAMBRIDGE, Mass., April 30 /PRNewswire/ -- Virtify, Inc. (, the market leader in Enterprise Content Compliance solutions for life sciences, and Pilgrim Software (, a provider of Enterprise Compliance and Quality Management (ECQM) software solutions, will host a complimentary Webinar on best practices in SPL R4 compliance and how organizations can make the necessary transitions required by the new June 2009 mandate. The Webinar will take place on Thursday, May 7th at 11:00 a.m. EDT and feature Dr. Satish Tadikonda, founder and president of Virtify, Inc. This Webinar is for all human health, animal health, biologics and vaccines organizations and medical device companies who are modifying in-house systems or evaluating new technologies to meet the new SPL R4 requirements. The webinar is designed as a "how to" primer on complying with SPL R4.

Attendees will learn about:

  • Best practices for complying with SPL R4
  • Accelerating the conversion process from SPL R3 submissions to SPL R4 submissions
  • Automating the information transfer to SPL XML structure
  • Managing the changes involved with SPL R4 and streamlining submissions planning, preparation and tracking
  • Performing in-depth validation and QC for SPL R4 information

Title: "Best Practices for SPL R4 Compliance for Life Sciences Companies - Are You Ready for the June 2009 Mandate?"

Presenter: Dr. Satish Tadikonda, founder and president, Virtify, Inc.

Date/Time: Thursday, May 7 at 11:00 am EDT

To Register:

About Dr. Tadikonda

Dr. Tadikonda is founder and president of Virtify, Inc. With 20+ years in the drug and medical device industries, Tadikonda has a deep understanding of drug discovery and development processes, significant experience with global clinical and regulatory submission standards, and has been actively involved in leading and participating in the development of electronic standards for the industry. Prior to Virtify, Tadikonda founded companies focused on electronic data capture and R&D systems integration and held senior management positions with leading companies in the pharmaceutical and medical device industries.

About Virtify

Virtify is the market leader in Enterprise Content Compliance solutions for Life Sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use Virtx software suite is the industry's only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum -- from pre-clinical through product registration to commercialization. The company plays a leadership role in the development of global regulatory standards and is an active participant in a variety of standards committees. Virtify's software products, combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's leading life sciences companies.

Virtify is headquartered in Cambridge, Massachusetts (USA) with facilities in Europe and Asia. For more information, visit

About Pilgrim Software, Inc.

Pilgrim Software, Inc. is a world-leading provider of Enterprise Compliance and Quality Management solutions for global organizations. Named 2007 & 2008 North American Enterprise Compliance & Quality Management Company of the Year by Frost & Sullivan, Pilgrim helps organizations manage industry and regulatory compliance, reduce manufacturing costs and improve customer satisfaction. For more information, visit Pilgrim Software's website at

SOURCE Virtify, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
2. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
3. Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
4. Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
5. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
6. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
7. IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its Embracing Human Technology Interactions Media Event
8. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
9. Ecologists propose first prevention for white-nose syndrome death in bats
10. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
11. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
Post Your Comments:
(Date:11/25/2015)... 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today ... rights plan (Rights Plan) in an effort to preserve ... under Section 382 of the Internal Revenue Code (Code). ... use of its NOLs could be substantially limited if ... Section 382 of the Code. In general, an ownership ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and CEO of Neurocrine Biosciences, will be ... in New York . ... the website approximately 5 minutes prior to the presentation ... of the presentation will be available on the website ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015  As new scientific discoveries deepen our ... other healthcare providers face challenges in better using that ... In addition, as more children continue to survive pediatric ... and old age. John M. Maris, M.D ... of Philadelphia (CHOP) . --> John ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
Breaking Biology News(10 mins):